Authors:
Geisel, R
Schmitz, FJ
Fluit, AC
Labischinski, H
Citation: R. Geisel et al., Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus, EUR J CL M, 20(10), 2001, pp. 685-697
Authors:
Schmitz, FJ
Hafner, D
Geisel, R
Follmann, P
Kirschke, C
Verhoef, J
Kohrer, K
Fluit, AC
Citation: Fj. Schmitz et al., Increased prevalence of class I integrons in Escherichia coli, Klebsiella species, and Enterobacter species isolates over a 7-year period in a Germanuniversity hospital, J CLIN MICR, 39(10), 2001, pp. 3724-3726
Authors:
Schmitz, FJ
Sadurski, R
Kray, A
Boos, M
Geisel, R
Kohrer, K
Verhoef, J
Fluit, AC
Citation: Fj. Schmitz et al., Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals, J ANTIMICRO, 45(6), 2000, pp. 891-894
Authors:
Schmitz, FJ
Krey, A
Geisel, R
Verhoef, J
Heinz, HP
Fluit, AC
Citation: Fj. Schmitz et al., Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolatesfrom 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds, EUR J CL M, 18(7), 1999, pp. 528-530
Authors:
Geisel, R
Schmitz, FJ
Thomas, L
Berns, G
Zetsche, O
Ulrich, B
Fluit, AC
Labischinsky, H
Witte, W
Citation: R. Geisel et al., Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf area, J ANTIMICRO, 43(6), 1999, pp. 846-848